Pyrimidopyrimidinones useful as Wee-1 kinase inhibitors

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9850247
APP PUB NO 20160318936A1
SERIAL NO

15105869

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to compounds that are useful as inhibitors of the activity of Wee-1 kinase. The present invention also relates to pharmaceutical compositions comprising these compounds and to methods of using these compounds in the treatment of cancer and methods of treating cancer.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
ALMAC DISCOVERY LIMITEDCRAIGAVON

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Burkamp, Frank Craigavon Armagh, GB 37 107
Harrison, Timothy Craigavon Armagh, GB 90 892
Hewitt, Peter Robin Craigavon Armagh, GB 1 5
Miel, Hugues Craigavon Armagh, GB 3 8
O'Dowd, Colin Roderick Craigavon Armagh, GB 4 10
Shepherd, Steven D Craigavon Armagh, GB 1 5
Trevitt, Graham Craigavon Armagh, GB 2 6
Wilkinson, Andrew John Craigavon Armagh, GB 4 8

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Jun 26, 2025
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jun 26, 2029
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00